Dr. Greg Mattingly, MD
Claim this profileMore about Greg Mattingly, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Greg Mattingly, MD has experience with
- ADHD Therapy
Breakdown of trials Greg Mattingly, MD has run
Attention-Deficit/Hyperactivity Disorder (ADHD)
Attention Deficit Hyperactivity Disorder (ADHD)
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Greg Mattingly, MD specialize in?
Greg Mattingly, MD focuses on Attention-Deficit/Hyperactivity Disorder (ADHD) and Attention Deficit Hyperactivity Disorder (ADHD). In particular, much of their work with Attention-Deficit/Hyperactivity Disorder (ADHD) has involved treating patients, or patients who are undergoing treatment.
Is Greg Mattingly, MD currently recruiting for clinical trials?
No, Greg Mattingly, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Greg Mattingly, MD has studied deeply?
Yes, Greg Mattingly, MD has studied treatments such as ADHD Therapy.
What is the best way to schedule an appointment with Greg Mattingly, MD?
Apply for one of the trials that Greg Mattingly, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.